TALACOTUZUMAB

UNII:	X8JR0I7JE1
Formula:
Preferred Substance Name:	TALACOTUZUMAB

1826831-79-1
ANTI-IL-3 RECEPTOR ALPHA MONOCLONAL ANTIBODY CSL362
CSL362
CSL-362
IMMUNOGLOBULIN G1-2-KAPPA, ANTI-(HOMO SAPIENS IL3RA (INTERLEUKIN 3 RECEPTOR SUBUNIT ALPHA, INTERLEUKIN 3 RECEPTOR ALPHA (LOW AFFINITY), CD123)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1-2 HEAVY CHAIN (1-450) (HUMANIZED VH (HOMO SAPIENS IGHV5-51*01 (82.70%) -(IGHD) -IGHJ3*01) (8.8.13) (1-120) -HOMO SAPIENS IGHG1*01 (CH1 G1M17, K120 (217) (121-218) -HINGE (219-233) -CH2 1.6-1.1 (234-239)) (121-239) -HOMO SAPIENS IGHG2*01 (CH2 1-125, S3>D (242), G2M.. V45.1 (285), G110>A (330), I117>E (335) (240-343) -CH3 NG1M1 E12 (359), M14 (361) (344-448), CHS (449-450)) (240-450)), (223-220')-DISULFIDE WITH KAPPA LIGHT CHAIN (1-220) (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV4-1*01 (90.10%) -IGKJ2*01) (12.3.9) (1'-113') -HOMO SAPIENS IGKC*01, KM3 A45.1 (159), V101 (197) (114'-220'))DIMER (229-229'':232-232'')-BISDISULFIDE
JNJ-56022473
TALACOTUZUMAB [INN]
TALACOTUZUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TALACOTUZUMAB

Synonyms and Mappings

Resources